DCGI approved QR 678 formulation proves to be a differentiator from traditional hair transplant treatment
The QR 678 ® therapy has also demonstrated encouraging results in post chemotherapy induced hair loss, treatment of hair conditions like seborrheic dermatitis and in immunogenic diseases like alopecia areata. By Dr. Debraj Shome Drugs Controller General of India (DCGI) approved QR 678 has bridged the gap in the hair regrowth market and has proven … Read more